EGFR and breast cancer: In MDA-MB-231 cells, miR-146 significantly downregulates epidermal growth factor receptor (EGFR) expression, inhibiting breast cancer cell invasion and migration in vitro and mitigating bone destruction (Hurst et al., 2009).